Roivant Sciences Ltd. (ROIV): SEC Filings & AI Analysis
Healthcare. Latest 10-K, 10-Q, and 8-K filings for Roivant Sciences Ltd. (ROIV) with AI risk scoring and cited answers, grounded in primary-source SEC EDGAR data.
Most recent filing — 8-K filed October 21, 2026: BULLISH Concern level: LOW.
Company overview — key questions
Answers are generated from SEC filings and StockHuntr's analysis. Not investment advice.
What is Roivant Sciences Ltd. (ROIV)?
Roivant Sciences Ltd. is a publicly traded company in the Healthcare space tracked on StockHuntr, which analyzes its SEC filings (10-K, 10-Q, 8-K) and generates 30-day stock predictions.
What are ROIV's most recent SEC filings?
Recent filings: 8-K (October 21, 2026), 8-K (September 18, 2026), 8-K (September 8, 2026), 8-K (August 28, 2026), 8-K (August 27, 2026).
What does ROIV's latest filing analysis show?
ROIV's most recent 8-K (October 21, 2026) is rated BULLISH, concern level LOW.
Is ROIV a buy?
StockHuntr doesn't issue buy or sell ratings — it's a research tool. For Roivant Sciences Ltd. (ROIV), its latest 8-K is rated LOW concern. Weigh these filing-based signals alongside your own research. This is model analysis for research, not investment advice.
Recent ROIV filings analyzed
Other Healthcare companies
About this analysis
- Primary source:
- View this company's filings on SEC EDGAR
- Additional data:
- Yahoo Finance (market data)
- Method:
- StockHuntr analyzes filings with AI — see our methodology.
- Analysis as of:
- October 21, 2026
- Published by:
- StockHuntr
For research and education only. Nothing here is investment advice.
Loading ROIV snapshot...
Fetching live market data